Skip to main content
Back
Watch Compare

Cardio Diagnostics Holdings, Inc.

Data quality: 100%
Also listed as CDIOW Nasdaq
CDIO
Nasdaq Manufacturing Chemicals
$1.81
▼ $0.22 (-10.84%)
Mkt Cap: 5.36 M
Price
$1.81
Mkt Cap
5.36 M
Day Range
$1.80 — $2.08
52-Week Range
$0.97 — $17.40
Volume
163,907
Open $2.08
50D / 200D Avg
$2.70
32.92% below
50D / 200D Avg
$3.40
46.73% below

Quick Summary

Key Takeaways

Negative free cash flow of -5.91 M
Capital intensive — 1263.52% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-57.51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-72.70%
Below sector avg (-53.41%)
ROIC-55.63%
Net Margin-43832.49%
Op. Margin-43737.46%

Safety

Debt / Equity
N/A
Current Ratio17.39
Interest Coverage-438.08

Valuation

PE (TTM)
-0.82
Above sector avg (-1.48)
P/B Ratio0.66
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.8 -1.5
P/B 0.7 1.6
ROE % -72.7 -53.4
Net Margin % -43832.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -57.51% Revenue Growth (3Y) -6.79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14,825.0 Net Income (TTM) -6.50 M
ROE -72.70% ROA -67.74%
Gross Margin N/A Operating Margin -43737.46%
Net Margin -43832.49% Free Cash Flow (TTM) -5.91 M
ROIC -55.63% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17.39
Interest Coverage -438.08 Asset Turnover 0.00
Working Capital 6.53 M Tangible Book Value 8.15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.82 Forward P/E N/A
P/B Ratio 0.66 P/S Ratio 361.32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -110.41%
Market Cap 5.36 M Enterprise Value 5.36 M
Per Share
EPS (Diluted TTM) -3.71 Revenue / Share 0.01
FCF / Share -2.00 OCF / Share -1.94
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1263.52% FCF Conversion 91.01%
SBC-Adj. FCF -6.02 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue 14,825.0 34,890.0 17,065.0 — 950.0
Net Income -6.50 M -8.38 M -8.38 M -144,837.0 -4.66 M
EPS (Diluted) -3.71 -0.31 -0.66 — -1.51
Gross Profit — — — — —
Operating Income -6.48 M -8.37 M -7.24 M -145,321.0 -4.55 M
EBITDA — — — — —
R&D Expenses 641,212.0 29,125.0 145,182.0 — 40,448.0
SG&A Expenses — — — — —
D&A 65,233.0 19,738.0 19,182.0 — 16,000.0
Interest Expense 14,801.0 18,640.0 6.74 M — —
Income Tax — — — — 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 7.77 M 10.62 M 4.46 M 65.81 M 6.25 M
Total Liabilities 793,061.0 1.06 M 1.50 M 124,434.0 1.95 M
Shareholders' Equity 6.97 M 9.56 M 2.96 M 682,732.0 4.30 M
Total Debt — — — — —
Cash & Equivalents 0.0 0.0 0.0 0.0 0.0
Current Assets 5.92 M 8.79 M 2.77 M 806,682.0 5.89 M
Current Liabilities 604,839.0 631,695.0 841,142.0 124,434.0 —